Mårten SteenManaging Partner at HealthCap
Mårten Steen, MD PhD is Managing Partner of HealthCap. Mårten has invested in and worked with many successful biotech companies including Ultragenyx, Wilson Therapeutics (acquired by Alexion/Astra Zeneca), Vivet Therapeutics and FerroKin (acquired by Shire/Takeda). Previously, he has worked with business development at Merck Serono and pursued research in the field of coagulation disorders at Lund University and Novo Nordisk. He has also a B.Sc. degree in Business Administration.